您的购物车当前为空
BCAT-IN-4 是一种具有有效性的 BCAT 抑制剂 对 hBCATc 的 IC50 值为 2.35 μM。 BCAT-IN-4 具有抗癌活性,可用于研究胰腺导管腺癌。


为众多的药物研发团队赋能,
让新药发现更简单!
BCAT-IN-4 是一种具有有效性的 BCAT 抑制剂 对 hBCATc 的 IC50 值为 2.35 μM。 BCAT-IN-4 具有抗癌活性,可用于研究胰腺导管腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 546 | In Stock | |
| 5 mg | ¥ 1,360 | In Stock | |
| 10 mg | ¥ 1,990 | In Stock | |
| 25 mg | ¥ 3,130 | In Stock | |
| 50 mg | ¥ 4,130 | In Stock | |
| 100 mg | ¥ 5,710 | In Stock | |
| 200 mg | ¥ 7,560 | In Stock |
| 产品描述 | BCAT-IN-4 is a potent BCAT inhibitor with an IC50 value of 2.35 μM for hBCATc. BCAT-IN-4 has anticancer activity and can be used to study pancreatic ductal adenocarcinoma. |
| 靶点活性 | BCATc (human):2.35 μM |
| 分子量 | 366.39 |
| 分子式 | C19H14N2O4S |
| CAS No. | 406190-85-0 |
| Smiles | O=C(NNS(=O)(=O)C=1C=CC=CC1)C=2C=CC=3OC=4C=CC=CC4C3C2 |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (136.47 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容